Edwards Lifesciences Corporation

EW · Moat type: UNBESTIMMT

MoatScore

6/10

Fair Value

64 USD

Margin of Safety

-47.1 %

Rating

BEOBACHTEN

Edwards Lifesciences develops, manufactures, and distributes specialized heart valve therapies as well as hemodynamic monitoring systems for cardiac patients, with revenues primarily derived from the sale of catheter-based heart valve systems (TAVR) and critical patient monitoring solutions to cardiac surgery departments worldwide.

View full analysis →

🔒 Detailed AI analysis, peer comparison, capital allocation, crisis resilience & PDF report for Pro members.

Not investment advice. Analyses are research, not a recommendation. Valuations may be erroneous or incomplete. © MoatScan.ai — proprietary methodology.